Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt–Hogg–Dubé Syndrome

SIMPLE SUMMARY: Percutaneous thermal ablation (TA) could be a safe and efficient nephron-sparing treatment for treating renal cell carcinoma (RCCs) associated with Birt–Hogg–Dubé (BHD) syndrome, a rare hereditary condition at greater risk of repeated treatments, even in the case of advanced chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodard, Sylvain, Boudhabhay, Idris, Dariane, Charles, Delavaud, Christophe, Guinebert, Sylvain, Joly, Dominique, Timsit, Marc-Olivier, Mejean, Arnaud, Verkarre, Virginie, Hélénon, Olivier, Richard, Stéphane, Correas, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599652/
https://www.ncbi.nlm.nih.gov/pubmed/36291753
http://dx.doi.org/10.3390/cancers14204969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599652/
https://www.ncbi.nlm.nih.gov/pubmed/36291753
http://dx.doi.org/10.3390/cancers14204969

Ejemplares similares